NCT06933966View on ClinicalTrials.gov

Evaluation of Efficacy and Safety De-escalation Versus Standard Adjuvant Chemotherapy in Patients With Low Risk Localized Gastroesophageal Adenocarcinoma

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 1, 2030

Study Completion Date

September 1, 2032

Conditions
Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal CarcinomaNon Metastatic Disease
Interventions
OTHER

observation alone

Patient will not received post-operative chemotherapy. There will be only surveillance until progression.

Trial Locations (3)

13009

Institut Paoli-Calmettes, Marseille

69373

Centre Léon Bérard, Lyon

75012

AP-HP - Hôpital Saint-Antoine, Paris

All Listed Sponsors
lead

Centre Leon Berard

OTHER